Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
Beena E ThomasJ Vignesh KumarMurugesan PeriyasamyAmit Subhash KhandewaleJ Hephzibah MercyE Michael RajS KokilaApurva Shashikant WalgudeGunjan Rahul GaurkhedeJagannath Dattatraya KumbharSenthanro OvungMariyamma PaulB Sathyan RajkumarRamnath SubbaramanPublished in: Journal of medical Internet research (2021)
Several features of the MERM support its acceptability among patients with MDR-TB and HCPs, and some barriers to patient use could be addressed by improving the design of the device. However, some barriers, such as disease-related stigma, are more difficult to modify and may limit use of the MERM among some patients with MDR-TB. Further research is needed to assess the accuracy of MERM for measuring adherence, its effectiveness for improving treatment outcomes, and patients' sustained use of the device in larger scale implementation.
Keyphrases
- multidrug resistant
- healthcare
- mycobacterium tuberculosis
- end stage renal disease
- drug resistant
- systematic review
- acinetobacter baumannii
- ejection fraction
- newly diagnosed
- randomized controlled trial
- hiv aids
- chronic kidney disease
- mental health
- prognostic factors
- case report
- klebsiella pneumoniae
- emergency department
- escherichia coli
- type diabetes
- stem cells
- social support
- hepatitis c virus
- quality improvement
- human immunodeficiency virus
- cystic fibrosis
- social media
- electronic health record
- smoking cessation
- affordable care act